{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T22:10:24Z","timestamp":1691705424278},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s11910-015-0565-x","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T14:13:37Z","timestamp":1432563217000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuromuscular Issues in Systemic Disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Wolfgang","family":"Grisold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grisold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"key":"565_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1529-8027.2008.00169.x","volume":"13","author":"S Van Nes","year":"2008","unstructured":"Van Nes S, Faber CG, Merkies IS. Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials. J Peripher Nerv Syst. 2008;13:136\u201347.","journal-title":"J Peripher Nerv Syst"},{"key":"565_CR2","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.2337\/dc12-2075","volume":"36","author":"GA Sivaskandarajah","year":"2013","unstructured":"Sivaskandarajah GA, Halpern EM, Lovblom LE, et al. Structure-function relationship between corneal nerves and conventional small-fiber tests in type 1 diabetes. Diabetes Care. 2013;36:2748\u201355.","journal-title":"Diabetes Care"},{"key":"565_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/brb3.26","volume":"1","author":"J Lindh","year":"2011","unstructured":"Lindh J, Soderkvist P, Fredrikson M, et al. Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case\u2013control study. Brain Behav. 2011;1:135\u201341.","journal-title":"Brain Behav"},{"key":"565_CR4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/mus.23900","volume":"48","author":"MS Cartwright","year":"2013","unstructured":"Cartwright MS, Walker FO. Neuromuscular ultrasound in common entrapment neuropathies. Muscle Nerve. 2013;48:696\u2013704.","journal-title":"Muscle Nerve"},{"key":"565_CR5","first-page":"223","volume":"66","author":"T Sugimoto","year":"2014","unstructured":"Sugimoto T, Ochi K, Hosomi N, Matsumoto M. Ultrasonographic diagnosis of inflammatory neuropathies. Brain Nerve. 2014;66:223\u20138. Article in Japanese.","journal-title":"Brain Nerve"},{"key":"565_CR6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/mus.24227","volume":"50","author":"CM Zaidman","year":"2014","unstructured":"Zaidman CM, Pestronk A. Nerve size in chronic inflammatory demyelinating neuropathy varies with disease activity and therapy response over time: a retrospective ultrasound study. Muscle Nerve. 2014;50:733\u20138.","journal-title":"Muscle Nerve"},{"key":"565_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2014.08.026","author":"SH Goedee","year":"2014","unstructured":"Goedee SH, Brekelmans GJ, van den Berg LH, Visser LH. Distinctive patterns of sonographic nerve enlargement in Charcot-Marie-Tooth type 1A and hereditary neuropathy with pressure palsies. Clin Neurophysiol. 2014. doi:10.1016\/j.clinph.2014.08.026.","journal-title":"Clin Neurophysiol"},{"key":"565_CR8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.0b013e31820d62eb","volume":"76","author":"C Briani","year":"2011","unstructured":"Briani C, Vitaliani R, Grisold W, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011;76:705\u201310.","journal-title":"Neurology"},{"key":"565_CR9","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.autrev.2014.08.018","volume":"13","author":"MG Danieli","year":"2014","unstructured":"Danieli MG, Gelardi C, Pedini V, et al. Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. Autoimmun Rev. 2014;13:1182\u20138.","journal-title":"Autoimmun Rev"},{"key":"565_CR10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","volume":"76","author":"I Cortese","year":"2011","unstructured":"Cortese I, Chaudhry V, So YT, et al. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76:294\u2013300.","journal-title":"Neurology"},{"key":"565_CR11","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.3928\/01477447-20140401-57","volume":"37","author":"H Sugaya","year":"2014","unstructured":"Sugaya H, Tanaka T, Ogawa T, Mishima H. Spinal epidural lipomatosis in lumbar magnetic resonance imaging scans. Orthopedics. 2014;37:e362\u20136.","journal-title":"Orthopedics"},{"key":"565_CR12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2014.08.018","volume":"346","author":"KE Kim","year":"2014","unstructured":"Kim KE. Characteristic features of hereditary neuropathy with liability to pressure palsy (HNPP) presenting with brachial plexopathy in soldiers. J Neurol Sci. 2014;346:174\u20137. This is a large study addressing different types of brachial plexus lesions. The history of physical exercise as pushups, and an asymptomatic prolongation of distal latency of the median nerve are diagnostic clues for HNPP.","journal-title":"J Neurol Sci"},{"key":"565_CR13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jhsa.2014.10.033","volume":"40","author":"CJ Dy","year":"2015","unstructured":"Dy CJ, Garg R, Lee SK, et al. A systematic review of outcomes reporting for brachial plexus reconstruction. J Hand Surg [Am]. 2015;40:308\u201313.","journal-title":"J Hand Surg [Am]"},{"key":"565_CR14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1102\/1470-7330.2013.0052","volume":"13","author":"N Brejt","year":"2013","unstructured":"Brejt N, Berry J, Nisbet A, et al. Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge. Cancer Imaging. 2013;13:591\u2013601.","journal-title":"Cancer Imaging"},{"key":"565_CR15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/mus.24453","volume":"50","author":"R Shiri","year":"2014","unstructured":"Shiri R. Hypothyroidism and carpal tunnel syndrome: a meta-analysis. Muscle Nerve. 2014;50:879\u201383.","journal-title":"Muscle Nerve"},{"key":"565_CR16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3346\/jkms.2011.26.9.1227","volume":"26","author":"HK Kwon","year":"2011","unstructured":"Kwon HK, Pyun SB, Cho WY, Boo CS. Carpal tunnel syndrome and peripheral polyneuropathy in patients with end stage kidney disease. J Korean Med Sci. 2011;26:1227\u201330.","journal-title":"J Korean Med Sci"},{"key":"565_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24506","author":"MD Stubblefield","year":"2014","unstructured":"Stubblefield MD, Kim A, Riedel ER, Ibanez K. Carpal tunnel syndrome in breast cancer survivors with upper extremity lymphedema. Muscle Nerve. 2014. doi:10.1002\/mus.24506.","journal-title":"Muscle Nerve"},{"key":"565_CR18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3816\/CBC.2008.n.043","volume":"8","author":"T Nishihori","year":"2008","unstructured":"Nishihori T, Choi J, DiGiovanna MP, et al. Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer. Clin Breast Cancer. 2008;8:362\u20135.","journal-title":"Clin Breast Cancer"},{"key":"565_CR19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mus.21561","volume":"41","author":"JA Tracy","year":"2010","unstructured":"Tracy JA, Dyck PJ, Dyck PJ. Primary amyloidosis presenting as upper limb multiple mononeuropathies. Muscle Nerve. 2010;41:710\u20135.","journal-title":"Muscle Nerve"},{"key":"565_CR20","first-page":"651","volume":"2015","author":"JC Ha","year":"1852","unstructured":"Ha JC, Richman DP. Myasthenia gravis and related disorders: pathology and molecular pathogenesis. Biochim Biophys Acta. 1852;2015:651\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"565_CR21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun. 2014;52:90\u2013100.","journal-title":"J Autoimmun"},{"key":"565_CR22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/WCO.0000000000000136","volume":"27","author":"SW Reddel","year":"2014","unstructured":"Reddel SW, Morsch M, Phillips WD. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis. Curr Opin Neurol. 2014;27:558\u201365.","journal-title":"Curr Opin Neurol"},{"key":"565_CR23","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","volume":"123","author":"C Shen","year":"2013","unstructured":"Shen C, Lu Y, Zhang B, et al. Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. J Clin Invest. 2013;123:5190\u2013202.","journal-title":"J Clin Invest"},{"key":"565_CR24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cei.12217","volume":"175","author":"JP Sieb","year":"2014","unstructured":"Sieb JP. Myasthenia gravis: an update for the clinician. Clin Exp Immunol. 2014;175:408\u201318.","journal-title":"Clin Exp Immunol"},{"key":"565_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","volume":"10","author":"G Cea","year":"2013","unstructured":"Cea G, Benatar M, Verdugo RJ, Salinas RA. Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev. 2013;10, CD008111. doi:10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"key":"565_CR26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/icvts\/ivt493","volume":"18","author":"JK Ng","year":"2014","unstructured":"Ng JK, Ng CS, Underwood MJ, Lau KK. Does repeat thymectomy improve symptoms in patients with refractory myasthenia gravis? Interact Cardiovasc Thorac Surg. 2014;18:376\u201380.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"565_CR27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11940-014-0283-8","volume":"16","author":"K El-Salem","year":"2014","unstructured":"El-Salem K, Yassin A, Al-Hayk K, et al. Treatment of MuSK-associated myasthenia gravis. Curr Treat Options Neurol. 2014;16:283.","journal-title":"Curr Treat Options Neurol"},{"key":"565_CR28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2014.07.060","volume":"346","author":"I Basta","year":"2014","unstructured":"Basta I, Pekmezovic T, Peric S, et al. Extrathymic malignancies in a defined cohort of patients with myasthenia gravis. J Neurol Sci. 2014;346:80\u20134.","journal-title":"J Neurol Sci"},{"key":"565_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","volume":"10","author":"MM Mehndiratta","year":"2014","unstructured":"Mehndiratta MM, Pandey S, Kuntzer T. Acetylcholinesterase inhibitor treatment for myasthenia gravis. Cochrane Database Syst Rev. 2014;10, CD006986. doi:10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"key":"565_CR30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ane.12261","volume":"130","author":"S Hoffmann","year":"2014","unstructured":"Hoffmann S, Kohler S, Ziegler A, Meisel A. Glucocorticoids in myasthenia gravis\u2014if, when, how, and how much? Acta Neurol Scand. 2014;130:211\u201321.","journal-title":"Acta Neurol Scand"},{"key":"565_CR31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CND.0000000000000034","volume":"15","author":"NJ Silvestri","year":"2014","unstructured":"Silvestri NJ, Wolfe GI. Treatment-refractory myasthenia gravis. J Clin Neuromuscul Dis. 2014;15:167\u201378.","journal-title":"J Clin Neuromuscul Dis"},{"key":"565_CR32","doi-asserted-by":"crossref","unstructured":"Iorio R, Damato V, Alboini PE, Evoli A. Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis. J Neurol. 2014.","DOI":"10.1007\/s00415-014-7532-3"},{"key":"565_CR33","unstructured":"Alexion Pharmaceuticals Inc. (press release) (Cheshire CS, 2011. \u201c34. Phase 2 study of eculizumab (Soliris\u00ae) in patients with severe and refractory generalized myasthenia gravis presented at MGFR annual meeting\u201d. Alexion Pharmaceuticals Inc (press release) (Cheshire, CT) September 14, 2011."},{"key":"565_CR34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cca.2015.01.042","volume":"444","author":"J Oger","year":"2015","unstructured":"Oger J, Frykman H. An update on laboratory diagnosis in myasthenia gravis. Clin Chim Acta. 2015;444:126\u201331.","journal-title":"Clin Chim Acta"},{"key":"565_CR35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mus.23964","volume":"48","author":"NM Alkhawajah","year":"2013","unstructured":"Alkhawajah NM, Oger J. Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing. Muscle Nerve. 2013;48:705\u201310.","journal-title":"Muscle Nerve"},{"key":"565_CR36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mus.24295","volume":"51","author":"RK Hajela","year":"2015","unstructured":"Hajela RK, Huntoon KM, Atchison WD. Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels. Muscle Nerve. 2015;51:176\u201384.","journal-title":"Muscle Nerve"},{"key":"565_CR37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/CMAR.S44261","volume":"6","author":"AA Argyriou","year":"2014","unstructured":"Argyriou AA, Kyritsis AP, Makatsoris T, Kalofonos HP. Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature. Cancer Manag Res. 2014;6:135\u201347.","journal-title":"Cancer Manag Res"},{"key":"565_CR38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1213\/ANE.0b013e31823526bf","volume":"114","author":"CG Frick","year":"2012","unstructured":"Frick CG, Fink H, Blobner M, Martyn J. A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites. Anesth Analg. 2012;114:102\u20139.","journal-title":"Anesth Analg"},{"key":"565_CR39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1212\/WNL.0000000000001160","volume":"84","author":"NA Visser","year":"2015","unstructured":"Visser NA, Notermans NC, Linssen RS, et al. Incidence of polyneuropathy in Utrecht, the Netherlands. Neurology. 2015;84:259\u201364.","journal-title":"Neurology"},{"key":"565_CR40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ncl.2013.02.004","volume":"31","author":"M Pasnoor","year":"2013","unstructured":"Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ. Diabetic neuropathy part 1: overview and symmetric phenotypes. Neurol Clin. 2013;31:425\u201345.","journal-title":"Neurol Clin"},{"key":"565_CR41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ncl.2013.02.003","volume":"31","author":"M Pasnoor","year":"2013","unstructured":"Pasnoor M, Dimachkie MM, Barohn RJ. Diabetic neuropathy part 2: proximal and asymmetric phenotypes. Neurol Clin. 2013;31:447\u201362.","journal-title":"Neurol Clin"},{"key":"565_CR42","first-page":"531","volume":"20","author":"V Bril","year":"2014","unstructured":"Bril V. Neuromuscular complications of diabetes mellitus. Continuum (Minneap Minn). 2014;20:531\u201344.","journal-title":"Continuum (Minneap Minn)"},{"key":"565_CR43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fendo.2014.00205","volume":"5","author":"A Verrotti","year":"2014","unstructured":"Verrotti A, Prezioso G, Scattoni R, Chiarelli F. Autonomic neuropathy in diabetes mellitus. Front Endocrinol. 2014;5:205.","journal-title":"Front Endocrinol"},{"key":"565_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/awu307","volume":"138","author":"CH Gibbons","year":"2015","unstructured":"Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015;138:43\u201352. \u201cInsulin neuritis\u201d is a treatment induced neuropathy, caused by rapid correction of glycemic control in patients with chronic hyperglycinemia. It s characterized by onset of acute pain or autonomic dysfunction within 8 weeks of inprovement of glycemic control, defined by a decrease in glycosylated haemoglobin A1C (HbA1c). Treatment-induced neuropathy of diabetes is an underestimated iatrogenic disorder associated with diffuse microvascular complications.","journal-title":"Brain"},{"key":"565_CR45","first-page":"438","volume":"18","author":"F Fatehi","year":"2013","unstructured":"Fatehi F, Nafissi S, Basiri K, et al. Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus. J Res Med Sci. 2013;18:438\u201341.","journal-title":"J Res Med Sci"},{"key":"565_CR46","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2169\/internalmedicine.53.2322","volume":"53","author":"W Chebbi","year":"2014","unstructured":"Chebbi W, Jerbi S, Klii R, et al. Multifocal diabetic muscle infarction: a rare complication of poorly controlled diabetes mellitus. Intern Med. 2014;53:2091\u20134.","journal-title":"Intern Med"},{"key":"565_CR47","doi-asserted-by":"publisher","unstructured":"Chaudhry V, Russel J, Belzberg A. Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy. Cochrane Database Syst Rev 2008;CD006152.doi:10.1002\/14651858","DOI":"10.1002\/14651858"},{"key":"565_CR48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.nrl.0000263699.53969.e9","volume":"13","author":"K Al-Hayk","year":"2007","unstructured":"Al-Hayk K, Bertorini TE. Neuromuscular complications in uremics: a review. Neurologist. 2007;13:188\u201396.","journal-title":"Neurologist"},{"key":"565_CR49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5301\/jn.5000087","volume":"25","author":"MA Rizzo","year":"2012","unstructured":"Rizzo MA, Frediani F, Granata A, et al. Neurological complications of hemodialysis: state of the art. J Nephrol. 2012;25:170\u201382.","journal-title":"J Nephrol"},{"key":"565_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","volume":"344","author":"R El-Abassi","year":"2014","unstructured":"El-Abassi R, Singhal D, England JD. Fabry\u2019s disease. J Neurol Sci. 2014;344:5\u201319.","journal-title":"J Neurol Sci"},{"key":"565_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-9158-3-19","volume":"3","author":"M Ueda","year":"2014","unstructured":"Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener. 2014;3:19.","journal-title":"Transl Neurodegener"},{"key":"565_CR52","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","volume":"310","author":"JL Berk","year":"2013","unstructured":"Berk JL, Suhr OB, Obici L, et al. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA. 2013;310:2658\u201367.","journal-title":"JAMA"},{"key":"565_CR53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"BR Wakerley","year":"2014","unstructured":"Wakerley BR, Uncini A, Yuki N, et al. Guillain\u2013Barr\u00e9 and Miller Fisher syndromes-new diagnostic classification. Nat Rev Neurol. 2014;10:537\u201344.","journal-title":"Nat Rev Neurol"},{"key":"565_CR54","first-page":"567","volume":"10","author":"VH Lawson","year":"2014","unstructured":"Lawson VH, Arnold WD. Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment. Neuropsychiatr Dis Treat. 2014;10:567\u201376.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"565_CR55","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ncl.2013.01.001","volume":"31","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie MM, Barohn RJ, Katz J. Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants. Neurol Clin. 2013;31:533\u201355.","journal-title":"Neurol Clin"},{"key":"565_CR56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S0317167100011483","volume":"38","author":"CJ Klein","year":"2011","unstructured":"Klein CJ, Moon JS, Mauermann ML, et al. The neuropathies of Waldenstrom\u2019s macroglobulinemia (WM) and IgM-MGUS. Can J Neurol Sci. 2011;38:289\u201395.","journal-title":"Can J Neurol Sci"},{"key":"565_CR57","first-page":"1307","volume":"20","author":"ML Mauermann","year":"2014","unstructured":"Mauermann ML. Paraproteinemic neuropathies. Continuum (Minneap Minn). 2014;20:1307\u201322.","journal-title":"Continuum (Minneap Minn)"},{"key":"565_CR58","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/brain\/awq252","volume":"133","author":"NP Staff","year":"2010","unstructured":"Staff NP, Engelstad J, Klein CJ, et al. Post-surgical inflammatory neuropathy. Brain. 2010;133:2866\u201380.","journal-title":"Brain"},{"key":"565_CR59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1529-8027.2010.00281.x","volume":"15","author":"MP Collins","year":"2010","unstructured":"Collins MP, Dyck PJ, Gronseth GS, et al. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst. 2010;15:176\u201384.","journal-title":"J Peripher Nerv Syst"},{"key":"565_CR60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","volume":"13","author":"KG Gwathmey","year":"2014","unstructured":"Gwathmey KG, Burns TM, Collins MP, Dyck PJ. Vasculitic neuropathies. Lancet Neurol. 2014;13:67\u201382.","journal-title":"Lancet Neurol"},{"key":"565_CR61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamaneurol.2014.3552","volume":"72","author":"R Lautner","year":"2015","unstructured":"Lautner R, Zetterberg H, Blennow K. Laboratory testing for lyme neuroborreliosis. JAMA Neurol. 2015;72:125\u20136.","journal-title":"JAMA Neurol"},{"key":"565_CR62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/1471-2334-12-344","volume":"12","author":"JP Borde","year":"2012","unstructured":"Borde JP, Meier S, Fingerle V, et al. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings. BMC Infect Dis. 2012;12:344.","journal-title":"BMC Infect Dis"},{"key":"565_CR63","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/B978-0-444-52902-2.00032-1","volume":"115","author":"K Hansen","year":"2013","unstructured":"Hansen K, Crone C, Kristoferitsch W. Lyme neuroborreliosis. Handb Clin Neurol. 2013;115:559\u201375.","journal-title":"Handb Clin Neurol"},{"key":"565_CR64","first-page":"243","volume":"5","author":"SG Sch\u00fctz","year":"2013","unstructured":"Sch\u00fctz SG, Robinson-Papp J. HIV-related neuropathy: current perspectives. HIV\/AIDS (Auckl). 2013;5:243\u201351.","journal-title":"HIV\/AIDS (Auckl)"},{"key":"565_CR65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1545109712442798","volume":"11","author":"JR Golbus","year":"2012","unstructured":"Golbus JR, Gallagher G, Blackburn G, Cinti S. Polyneuropathy associated with the diffuse infiltrative lymphocytosis syndrome. J Int Assoc Physicians AIDS Care (Chic). 2012;11:223\u20136.","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"565_CR66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/mus.24141","volume":"50","author":"LK Jones Jr","year":"2014","unstructured":"Jones Jr LK, Reda H, Watson JC. Clinical, electrophysiologic, and imaging features of zoster-associated limb paresis. Muscle Nerve. 2014;50:177\u201385.","journal-title":"Muscle Nerve"},{"key":"565_CR67","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/1871528113666140908113841","volume":"13","author":"S Mariotto","year":"2014","unstructured":"Mariotto S, Ferrari S, Monaco S. HCV-related central and peripheral nervous system demyelinating disorders. Inflamm Allergy Drug Targets. 2014;13:299\u2013304.","journal-title":"Inflamm Allergy Drug Targets"},{"key":"565_CR68","first-page":"37","volume":"3","author":"AA Leis","year":"2012","unstructured":"Leis AA, Stokic DS. Neuromuscular manifestations of west nile virus infection. Front Neurol. 2012;3:37.","journal-title":"Front Neurol"},{"key":"565_CR69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2014.08.044","volume":"346","author":"R Verma","year":"2014","unstructured":"Verma R, Sahu R, Holla V. Neurological manifestations of dengue infection: a review. J Neurol Sci. 2014;346:26\u201334.","journal-title":"J Neurol Sci"},{"key":"565_CR70","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/mus.23615","volume":"47","author":"D Lacomis","year":"2013","unstructured":"Lacomis D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve. 2013;47:452\u201363.","journal-title":"Muscle Nerve"},{"key":"565_CR71","doi-asserted-by":"publisher","first-page":"e75696","DOI":"10.1371\/journal.pone.0075696","volume":"8","author":"N Lantronico","year":"2013","unstructured":"Lantronico N, Filosto M, Fagoni N, et al. Small nerve fiber pathology in critical illness. PLoS ONE. 2013;8:e75696. doi:10.1371\/journal.pone.0075696.","journal-title":"PLoS ONE"},{"key":"565_CR72","doi-asserted-by":"publisher","first-page":"CD006832","DOI":"10.1002\/14651858","volume":"21","author":"G Hermans","year":"2009","unstructured":"Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev. 2009;21:CD006832. doi:10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"key":"565_CR73","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/B978-0-7020-4088-7.00089-4","volume":"121","author":"SA Zivkovic","year":"2014","unstructured":"Zivkovic SA. Neurologic aspects of multiple organ transplantation. Handb Clin Neurol. 2014;121:1305\u201317.","journal-title":"Handb Clin Neurol"},{"key":"565_CR74","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.0000000000001188","volume":"84","author":"M Nolano","year":"2015","unstructured":"Nolano M, Manganelli F, Provitera V, et al. Small nerve fiber involvement in CMT1A. Neurology. 2015;84:407\u201314.","journal-title":"Neurology"},{"key":"565_CR75","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1468-1331.2010.03023.x","volume":"17","author":"G Lauria","year":"2010","unstructured":"Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2010;17:903\u201312.","journal-title":"Eur J Neurol"},{"key":"565_CR76","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/ICO.0000000000000152","volume":"33","author":"C Dehghani","year":"2014","unstructured":"Dehghani C, Pritchard N, Edwards K, et al. Fully automated, semiautomated, and manual morphometric analysis of corneal subbasal nerve plexus in individuals with and without diabetes. Cornea. 2014;33:696\u2013702.","journal-title":"Cornea"},{"key":"565_CR77","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/j.jaad.2014.08.040","volume":"71","author":"M Patel","year":"2014","unstructured":"Patel M, Femia AN, Eastham AB, et al. Facial erythromelalgia: a rare entity to consider in the differential diagnosis of connective tissue diseases. J Am Acad Dermatol. 2014;71:e250\u20131.","journal-title":"J Am Acad Dermatol"},{"key":"565_CR78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/IJGM.S78848","volume":"8","author":"U Wollina","year":"2015","unstructured":"Wollina U. Burning feet in polycythemia vera - peripheral sensorimotor axonal neuropathy with erythromelalgia. Int J Gen Med. 2015;8:69\u201371.","journal-title":"Int J Gen Med"},{"key":"565_CR79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/neuonc\/nos203","volume":"14","author":"W Grisold","year":"2012","unstructured":"Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol. 2012;14:45\u201354.","journal-title":"Neuro Oncol"},{"key":"565_CR80","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00520-014-2255-7","volume":"22","author":"F Mols","year":"2014","unstructured":"Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22:2261\u20139.","journal-title":"Support Care Cancer"},{"key":"565_CR81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","volume":"67","author":"B Giometto","year":"2010","unstructured":"Giometto B, Grisold W, Vitaliani R, et al. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67:330\u20135.","journal-title":"Arch Neurol"},{"key":"565_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","volume":"12","author":"B Giometto","year":"2012","unstructured":"Giometto B, Vitaliani R, Lindeck-Pozza E, et al. Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev. 2012;12, CD007625. doi:10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"key":"565_CR83","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/brain\/awt193","volume":"136","author":"M Tomita","year":"2013","unstructured":"Tomita M, Koike H, Kawagashira Y, et al. Clinicopathological features of neuropathy associated with lymphoma. Brain. 2013;136:2563\u201378.","journal-title":"Brain"},{"key":"565_CR84","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.3109\/10428194.2012.691480","volume":"53","author":"CG Reddy","year":"2012","unstructured":"Reddy CG, Mauermann ML, Solomon BM, et al. Neuroleukemiosis: an unusual cause of peripheral neuropathy. Leuk Lymphoma. 2012;53:2405\u201311.","journal-title":"Leuk Lymphoma"},{"key":"565_CR85","first-page":"731","volume-title":"Neurologic complications in plasma cell dyscrasias","author":"E Bayat","year":"2012","unstructured":"Bayat E, Kelly JJ. Handbook of clinical neurology. In: Aminoff MJ, Boller F, Swaab DF, editors. Neurologic complications in plasma cell dyscrasias. Edinburgh: Elsevier; 2012. p. 731\u201346."},{"key":"565_CR86","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","volume":"80","author":"JM Leger","year":"2013","unstructured":"Leger JM, Viala K, Nicolas G, et al. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy. Neurology. 2013;80:2217\u201325.","journal-title":"Neurology"},{"key":"565_CR87","first-page":"1242","volume":"27","author":"A Dispenzieri","year":"2013","unstructured":"Dispenzieri A, Buadi FK. A review of POEMS syndrome. Oncology (Williston Park). 2013;27:1242\u201350.","journal-title":"Oncology (Williston Park)"},{"key":"565_CR88","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","volume":"55","author":"C Ferri","year":"2002","unstructured":"Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol. 2002;55:4\u201313.","journal-title":"J Clin Pathol"},{"key":"565_CR89","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","volume":"343","author":"S Vernino","year":"2012","unstructured":"Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2012;343:847\u201355.","journal-title":"N Engl J Med"},{"key":"565_CR90","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.0b013e3182120147","volume":"76","author":"L Zilliox","year":"2011","unstructured":"Zilliox L, Peltier AC, Wren PA, et al. Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology. 2011;76:1099\u2013105.","journal-title":"Neurology"},{"key":"565_CR91","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer A, Meyer N, Schaeffer M, et al. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford). 2015;54:50\u201363.","journal-title":"Rheumatology (Oxford)"},{"key":"565_CR92","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","volume":"48\u201349","author":"L Iaccarino","year":"2014","unstructured":"Iaccarino L, Ghirardello A, Bettio S, et al. The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun. 2014;48\u201349:122\u20137.","journal-title":"J Autoimmun"},{"key":"565_CR93","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MD.0000000000000222","volume":"93","author":"Y Troyanov","year":"2014","unstructured":"Troyanov Y, Targoff IN, Payette MP, et al. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore). 2014;93:318\u201332.","journal-title":"Medicine (Baltimore)"},{"key":"565_CR94","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendewald","year":"2010","unstructured":"Bendewald MJ, Wetter DA, Li X, Davis MD. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010;146:26\u201330.","journal-title":"Arch Dermatol"},{"key":"565_CR95","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jdv.12591","volume":"29","author":"C Cuesta-Mateos","year":"2015","unstructured":"Cuesta-Mateos C, Colom-Fern\u00e1ndez B, Portero-Sainz I, et al. Autoantibodies against TIF-1-\u03b3 and CADM-140 in Spanish patients with clinically amyopathic dermatomyositis (CADM): clinical significance and diagnostic utility. J Eur Acad Dermatol Venereol. 2015;29:482\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"565_CR96","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","volume":"13","author":"M Mahler","year":"2014","unstructured":"Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev. 2014;13:367\u201371.","journal-title":"Autoimmun Rev"},{"key":"565_CR97","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","volume":"14","author":"A Ceribelli","year":"2012","unstructured":"Ceribelli A, Fredi M, Taraborelli M, et al. Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/ dermatomyositis. Arthritis Res Ther. 2012;14:R97.","journal-title":"Arthritis Res Ther"},{"key":"565_CR98","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","volume":"261","author":"J van de Vlekkert","year":"2014","unstructured":"van de Vlekkert J, Hoogendjik JE, de Visser M. Long-term follow-up of 62 patients with myositis. J Neurol. 2014;261:992\u20138.","journal-title":"J Neurol"},{"key":"565_CR99","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/WNL.0b013e3182a35285","volume":"81","author":"KG Claeys","year":"2013","unstructured":"Claeys KG, Gorodinskaya O, Handt S, et al. Diagnostic challenge and therapeutic dilemma in necrotizing myopathy. Neurology. 2013;81:932\u20135.","journal-title":"Neurology"},{"key":"565_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/jjns2015.02.042","author":"S Babu","year":"2015","unstructured":"Babu S, Li Y. Statin induced necrotizing autoimmune myopathy. J Neurol Sci. 2015. doi:10.1016\/jjns2015.02.042.","journal-title":"J Neurol Sci"},{"key":"565_CR101","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.autrev.2014.01.017","volume":"13","author":"S Prieto-Gonz\u00e1lez","year":"2014","unstructured":"Prieto-Gonz\u00e1lez S, Grau JM. Diagnosis and classification of granulomatous myositis. Autoimmun Rev. 2014;13:372\u20134.","journal-title":"Autoimmun Rev"},{"key":"565_CR102","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","volume":"83","author":"TE Lloyd","year":"2014","unstructured":"Lloyd TE, Mammen AL, Amato AA, et al. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology. 2014;83:426\u201333.","journal-title":"Neurology"},{"key":"565_CR103","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/mus.24199","volume":"50","author":"SA Greenberg","year":"2014","unstructured":"Greenberg SA. Cytoplasmic 5\u2032-nucleotidase autoantibodies in inclusion body myositis: isotypes and diagnostic utility. Muscle Nerve. 2014;50:488\u201392.","journal-title":"Muscle Nerve"},{"key":"565_CR104","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/ene.12627","volume":"22","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Antal EA, Sveberg L, et al. High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Eur J Neurol. 2015;22:672\u2013e41.","journal-title":"Eur J Neurol"},{"key":"565_CR105","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","volume":"83","author":"AA Amato","year":"2014","unstructured":"Amato AA, Sivakumar K, Goyal, et al. Treatment of sporadic inclusion body myositis with bimagrumab. Neurology. 2014;83:2239\u201346. A small placebo controlled study showed promising results in the treatment of sporadic IBM. The inhibition of activin receptors IIA and IIB (ActRII) with the antibody bimagrumab. The outcome was measured by thigh volume and increase of walking distance.","journal-title":"Neurology"},{"key":"565_CR106","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72:241\u201355.","journal-title":"Ann Neurol"},{"key":"565_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24632","author":"A Ahmed","year":"2015","unstructured":"Ahmed A, Simmons Z. Isaacs syndrome: a review. Muscle Nerve. 2015. doi:10.1002\/mus.24632.","journal-title":"Muscle Nerve"},{"key":"565_CR108","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.1996.00550020113023","volume":"53","author":"CF Ansevin","year":"1996","unstructured":"Ansevin CF, Agamanolis DP. Rippling muscles and myasthenia gravis with rippling muscles. Arch Neurol. 1996;53:197\u20139.","journal-title":"Arch Neurol"},{"key":"565_CR109","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/art.22007","volume":"54","author":"AR Holmgren","year":"2006","unstructured":"Holmgren AR, Matteson EL. Lyme myositis. Arthritis Rheum. 2006;54:2697\u2013700.","journal-title":"Arthritis Rheum"},{"key":"565_CR110","first-page":"372470","volume":"2011","author":"A Sauer","year":"2011","unstructured":"Sauer A, Speeg-Schatz C, Hansmann Y. Two cases of orbital myositis as a rare feature of lyme borreliosis. Case Rep Infect Dis. 2011;2011:372470.","journal-title":"Case Rep Infect Dis"},{"key":"565_CR111","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jns.2014.12.012","volume":"348","author":"J Kalita","year":"2015","unstructured":"Kalita J, Misra UK, Mani VE, et al. A study of muscle involvement in scrub typhus. J Neurol Sci. 2015;348:226\u201330.","journal-title":"J Neurol Sci"},{"key":"565_CR112","first-page":"320","volume":"164","author":"P Madonia","year":"2012","unstructured":"Madonia P, Wilson J, Bican O, et al. HIV, rods, and the muscles\u2014a discussion about HIV-associated nemaline rod myopathy. J La State Med Soc. 2012;164:320\u20133.","journal-title":"J La State Med Soc"},{"key":"565_CR113","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11926-010-0104-3","volume":"12","author":"R Valiyil","year":"2010","unstructured":"Valiyil R, Christopher-Stine L. Drug-related myopathies of which the clinician should be aware. Curr Rheumatol Rep. 2010;12:213\u201320.","journal-title":"Curr Rheumatol Rep"},{"key":"565_CR114","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/pgs.12.11","volume":"13","author":"Q Feng","year":"2012","unstructured":"Feng Q, Wilke RA, Baye TM. Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions. Pharmacogenomics. 2012;13:579\u201394.","journal-title":"Pharmacogenomics"},{"key":"565_CR115","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00586-010-1370-5","volume":"19","author":"T Lenoir","year":"2010","unstructured":"Lenoir T, Guedj N, Boulu P, et al. Camptocormia: the bent spine syndrome, an update. Eur Spine J. 2010;19:1229\u201337.","journal-title":"Eur Spine J"},{"key":"565_CR116","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jnnp.2008.150011","volume":"80","author":"D Tiple","year":"2009","unstructured":"Tiple D, Fabbrini G, Colosimo C, et al. Camptocormia in Parkinson disease: an epidemiological and clinical study. J Neurol Neurosurg Psychiatry. 2009;80:145\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"565_CR117","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.maturitas.2011.11.012","volume":"71","author":"V Malafarina","year":"2012","unstructured":"Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L. Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas. 2012;71:109\u201314.","journal-title":"Maturitas"},{"key":"565_CR118","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146\u201356.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"565_CR119","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","volume":"5","author":"S Von Haehling","year":"2014","unstructured":"Von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers\u2014update 2014. J Cachex Sarcopenia Muscle. 2014;5:261\u20133.","journal-title":"J Cachex Sarcopenia Muscle"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-015-0565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-015-0565-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-015-0565-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-015-0565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T21:30:54Z","timestamp":1691703054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-015-0565-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1007\/s11910-015-0565-x","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,26]]},"assertion":[{"value":"26 May 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"48"}}